drugset / Trial / NCT00634491

Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

NCT00634491

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy

Timeline

Start
2007-09
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 250 mg Oral
Comparator normal salin Unknown
Comparator sodium bicarbonate Diagnostic / imaging agent Intravenous